Ortivus (ORTI) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 2025 rose 11% year-over-year to SEK 19.7 million, with gross margin improving to 51% from 30%.

• Adjusted EBITDA turned positive at SEK 0.4 million, compared to SEK -7.7 million last year.

• Net profit after tax for Q2 was SEK -6.5 million, an improvement from SEK -8.3 million year-over-year.

• Several major contract extensions in the UK secured over SEK 50 million in future revenues.

• A terminated project in Estonia negatively impacted Q2 earnings by SEK -5.1 million.

Financial highlights

• Q2 2025 net sales: SEK 19.7 million (up 11% year-over-year); H1 2025 net sales: SEK 37.8 million (down 5%).

• Q2 gross margin: 51% (30% last year); H1 gross margin: 46% (36% last year).

• Q2 EBITDA: SEK -4.7 million; Adjusted EBITDA: SEK 0.4 million.

• Q2 net profit after tax: SEK -6.5 million; H1 net profit after tax: SEK -8.9 million.

• Equity ratio at -26% at period end, down from 11% last year.

Outlook and guidance

• Board convened an extraordinary general meeting to propose a fully guaranteed rights issue of SEK 54 million to strengthen working capital and support product development.

• Anticipates increased procurement activity in the next 12–18 months and plans to expand in new markets like Ireland and Australia.

• No formal forecasts provided; forward-looking statements subject to risks and uncertainties.